This supplement should not be used as a substitute for a varied diet
However, the Korean RCT comparing the commonly prescribed OHA combinations (1:1:1 basis with fixed doses of glimepiride, metformin, and glimepiride plus metformin) to use as an add-on therapy with insulin glargine showed a significant improvement in overall glycemic control with insignificant weight gain and the risk of hypoglycemia in the arm of combination therapy of metformin and glimepiride plus glargine insulin [22]
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management and chronic weight management
Additionally, glycemic control is markedly improved, with a higher proportion of patients achieving normoglycemia or HbA1c 6.5% [167, 168]
Conclusion: This meta-analysis of RCTs provides reassuring evidence that GLP-1 receptor agonists were not associated with an increased risk of gastrointestinal cancers, with signals suggesting a possible reduction in colorectal and liver cancer incidence that should be interpreted cautiously
They actually think that Blastocystis hominis is a bacteria that is no longer pathogenic because it's everywhere
.jpg)
